These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 25884645

  • 1. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma.
    Chow AK, Cheng NS, Lam CS, Ng L, Wong SK, Wan TM, Man JH, Cheung AH, Yau TC, Poon JT, Law WL, Pang RW.
    Mol Cancer; 2015 Apr 11; 14():80. PubMed ID: 25884645
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. RAF265 inhibits the growth of advanced human melanoma tumors.
    Su Y, Vilgelm AE, Kelley MC, Hawkins OE, Liu Y, Boyd KL, Kantrow S, Splittgerber RC, Short SP, Sobolik T, Zaja-Milatovic S, Dahlman KB, Amiri KI, Jiang A, Lu P, Shyr Y, Stuart DD, Levy S, Sosman JA, Richmond A.
    Clin Cancer Res; 2012 Apr 15; 18(8):2184-98. PubMed ID: 22351689
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D, Fu L, Sun H, Guo L, DuBois RN.
    Gastroenterology; 2015 Dec 15; 149(7):1884-1895.e4. PubMed ID: 26261008
    [Abstract] [Full Text] [Related]

  • 6. AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
    Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, Toh HC, Thng CH, Chow P, Ong HS, Chung A, Goh BC, Smith PD, Soo KC.
    J Hepatol; 2010 Jan 15; 52(1):79-87. PubMed ID: 19910069
    [Abstract] [Full Text] [Related]

  • 7. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P, Arienti C, Amadori D, Fabbri F, Carloni S, Tesei A, Vannini I, Silvestrini R, Zoli W.
    J Cell Physiol; 2009 Jul 15; 220(1):214-21. PubMed ID: 19288493
    [Abstract] [Full Text] [Related]

  • 8. Gambogic Acid Efficiently Kills Stem-Like Colorectal Cancer Cells by Upregulating ZFP36 Expression.
    Wei F, Zhang T, Yang Z, Wei JC, Shen HF, Xiao D, Wang Q, Yang P, Chen HC, Hu H, Chen ZP, Huang Q, Li WL, Cao J.
    Cell Physiol Biochem; 2018 Jul 15; 46(2):829-846. PubMed ID: 29627822
    [Abstract] [Full Text] [Related]

  • 9. Synergistic action of a RAF inhibitor and a dual PI3K/mTOR inhibitor in thyroid cancer.
    Jin N, Jiang T, Rosen DM, Nelkin BD, Ball DW.
    Clin Cancer Res; 2011 Oct 15; 17(20):6482-9. PubMed ID: 21831957
    [Abstract] [Full Text] [Related]

  • 10. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.
    Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, Tan VP, Yau TC, Poon RT, Wong BC.
    Cell Stem Cell; 2010 Jun 04; 6(6):603-15. PubMed ID: 20569697
    [Abstract] [Full Text] [Related]

  • 11. Protein kinase D3 sensitizes RAF inhibitor RAF265 in melanoma cells by preventing reactivation of MAPK signaling.
    Chen J, Shen Q, Labow M, Gaither LA.
    Cancer Res; 2011 Jun 15; 71(12):4280-91. PubMed ID: 21527556
    [Abstract] [Full Text] [Related]

  • 12. The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells.
    Zitzmann K, de Toni E, von Rüden J, Brand S, Göke B, Laubender RP, Auernhammer CJ.
    Endocr Relat Cancer; 2011 Apr 15; 18(2):277-85. PubMed ID: 21317202
    [Abstract] [Full Text] [Related]

  • 13. The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways.
    Barollo S, Bertazza L, Baldini E, Ulisse S, Cavedon E, Boscaro M, Pezzani R, Mian C.
    Invest New Drugs; 2014 Aug 15; 32(4):626-35. PubMed ID: 24821574
    [Abstract] [Full Text] [Related]

  • 14. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy.
    Feng Y, Gao S, Gao Y, Wang X, Chen Z.
    Oncotarget; 2016 Dec 06; 7(49):81402-81409. PubMed ID: 27833077
    [Abstract] [Full Text] [Related]

  • 15. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
    Qi F, Wei L, Shen A, Chen Y, Lin J, Chu J, Cai Q, Pan J, Peng J.
    Oncol Rep; 2016 Jan 06; 35(1):511-7. PubMed ID: 26530025
    [Abstract] [Full Text] [Related]

  • 16. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
    Toden S, Tran HM, Tovar-Camargo OA, Okugawa Y, Goel A.
    Oncotarget; 2016 Mar 29; 7(13):16158-71. PubMed ID: 26930714
    [Abstract] [Full Text] [Related]

  • 17. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
    Buhrmann C, Yazdi M, Popper B, Shayan P, Goel A, Aggarwal BB, Shakibaei M.
    Nutrients; 2018 Jul 12; 10(7):. PubMed ID: 30002278
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas.
    Migliardi G, Sassi F, Torti D, Galimi F, Zanella ER, Buscarino M, Ribero D, Muratore A, Massucco P, Pisacane A, Risio M, Capussotti L, Marsoni S, Di Nicolantonio F, Bardelli A, Comoglio PM, Trusolino L, Bertotti A.
    Clin Cancer Res; 2012 May 01; 18(9):2515-25. PubMed ID: 22392911
    [Abstract] [Full Text] [Related]

  • 19. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer.
    Abdalla AN, Malki WH, Qattan A, Shahid I, Hossain MA, Ahmed M.
    Molecules; 2021 Jan 11; 26(2):. PubMed ID: 33440689
    [Abstract] [Full Text] [Related]

  • 20. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
    Wu W, Cao J, Ji Z, Wang J, Jiang T, Ding H.
    Oncotarget; 2016 Dec 06; 7(49):81144-81155. PubMed ID: 27835894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.